Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIORA pharmacogenomic follow-up blood collection study for namilumab-treated rheumatoid arthritis subjects
NL-OMON42614Phase 1Active, not recruiting
- Sponsor
- Takeda
- Start
- Feb 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of namilumab in rheumatoid arthritis (RA), sponsored by Takeda. Primary endpoint: Number of blood samples collected for genotyping. Started Feb 2016; status: active, not recruiting.
02
Drugs
namilumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON42614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42614.